Filter posts

ICYMI: Jim Greenwood Weighs In on the Future of Drug Pricing

Rewarding for quality – not quantity – is becoming more and more common in health …

ICYMI: Drug Development is Complicated. Let’s Start with the Facts.

Here’s a fact you might not have known: 90% of drug development programs fail. Yet …

Challenges and Opportunities in Personalized Medicine

Last week the sixth annual Patient and Health Advocacy Summit brought hundreds of patient advocates, …

ICYMI: Hope and Cures for Africa

For individuals and families across the globe, what were once considered deadly or debilitating diseases …

Patient and Industry Collaboration: Key to Successful Clinical Trials?

During the BIO Patient & Health Advocacy Summit last week, a panel led by Julie …

FDA’s Dr. Theresa Mullin Addresses BIO Patient and Health Advocacy Summit

“So, Theresa, where did you grow up? Did you have any siblings?” asked Marc Boutin, …

Welcome to the 2017 BIO Patient and Health Advocacy Summit!

Patients are at the forefront of everything we do. Each year BIO brings the patient …

Oncology Innovation Has Produced Major Drop in Pediatric Cancer Deaths

One of the toughest parts of working in the biotechnology industry is the likelihood that …

ICYMI: Citizens Against Government Waste Speaks Out Against Waste in 340B Drug Discount Program

Writing this week for The Hill, Elizabeth Wright of Citizens Against Government Waste highlights an …

Insurer Shifting Blame for Rising Premiums

According to a new report from Chad Terhune with Kaiser Health News, insurance giant Anthem …